Showing results (101-110 of 237) with videos related to
Sort By:
Pageof 24
Leukemia|February 29, 2008
The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells, and unwitting host to molecular parasitesY Shiozawa, A M Havens, K J Pienta, et al.Investigative Urology|July 1, 1975
Concepts and limitations in the application of radiolabeled antiandrogens, estrogens, or androgens as isotopic scanning agents for the prostateB Berger, D S Coffey, W W ScottArchives of Otolaryngology--Head & Neck Surgery|May 1, 1992
Nuclear morphometry for prediction of metastatic potential in early squamous cell carcinoma of the floor of the mouthR J Briggs, K J Pienta, R H Hruban, et al.The Prostate|June 1, 1995
Inhibition of prostate cancer growth by estramustine and colchicineM Fakih, A Yagoda, T Replogle, et al.American Journal of Clinical Oncology|October 1, 1996
A phase II evaluation of oral tamoxifen and intermittent intravenous vinblastine in hormone-refractory adenocarcinoma of the prostateK J Pienta, B G Redman, P S Esper, et al.Cancer Letters|July 16, 1993
A comparative study on expression of prostatic inhibin peptide, prostate acid phosphatase and prostate specific antigen in androgen independent human and rat prostate carcinoma cell linesS V Garde, A R Sheth, A T Porter, et al.Oncology Reports|June 19, 1998
The effect of amiloride on the metastatic properties of prostate cancer in the Dunning rat modelM J Pilat, J E Lehr, M M Quigley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Change in serum prostate-specific antigen as a marker of response to cytotoxic therapy for hormone-refractory prostate cancerD C Smith, R L Dunn, M S Strawderman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase II trial of oral estramustine, oral etoposide, and intravenous paclitaxel in hormone-refractory prostate cancerD C Smith, P Esper, M Strawderman, et al.Anticancer Research|August 15, 1998
Examination of the DNA methylation properties in nontumorigenic and tumorigenic breast epithelial cell linesM J Pilat, E D Schwab, K L Yao, et al.Pageof 24